| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |